Font Size:
a
A
A
Keyword [Human epidermal growth factor receptor]
Result: 81 - 100 | Page: 5 of 6
81.
Preparation Of Targeted Lipid Nano Ultrasound Contrast Agents With HSV-TK Suicide Gene And Its Target-finding Experiments In Vitro
82.
Effect Of Neoadjuvant Chemotherapy On Molecular Typing And Prognosis Of Breast Cancer
83.
Analysis Of Ultrasonic Multimodal Features Of Breast Cancer With Different HER-2 Expression
84.
Prognostic Analysis Of 311 Patients With Early HER2-Positive Breast Cancer
85.
Predictive Value Of HER2 Protein Expression Level In Pat Ients With HER2-positive Breast Cancer Receiving Neoadj Uvant Therapy
86.
Comparisons Of Efficacy And Safety Of Different Second-line Treatments For Trastuzumab-resistant Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
87.
The Influence And Mechanism Of HER-3 Knockdown On Radiosensitivity Of HER-2 Positive Breast Cancer Cells
88.
Clinical Pathological Practicing Analysis Of HER2 FISH Detection In Breast Cancer By2018 ASCO/CAP Updated Guidelines
89.
Molecular Targeted Combination Therapy For Human Epidermal Growth Factor Receptor 2-positive / Hormone Receptor Positive Advanced Breast Cancer: A Meta-analysis
90.
The Presence Of Calcification In Breast Cancer:Influence On The Response To Neoadjuvant Chemotherapy
91.
Biomarkers For Predicting Postoperative Prognosis And Chemotherapeutic Benefits In Resectable Gastric Cancer Patients Based On The Standardized Cohorts
92.
Differential Diagnosis Of Benign And Malignant Breast Lesions And Prediction Of HER2 2+ Status And TILs Levels Of Breast Cancer On MRI Radiomics
93.
Investigation Of Diagnosis,Prediction Of Metastasis And HER2 Status Of Breast Cancer On ABVS Ultrasound Radiomics
94.
Influencing Factors And Predictors Of Effect Of Pathological Complete Response Of HER2-positive Breast Cancer Treated With Neoadjuvant Treatment And Mechanism Of Drug Resistance
95.
The Value Of Predicting Human Epidermal Growth Factor Receptor 2 Status In Adenocarcinoma Of The Esophagogastric Junction In Different Models Of CT-based Radiomics
96.
Association Between Serum HER2/ErbB2 Levels And Risk Of Coronary Artery Disease
97.
Prognostic Analysis Of The Patients With HER-2 Positive Early Breast Cancer
98.
Role Of ErbB3 Overexpression In Tumor Metastasis Of ErbB2-positive Breast Cancer And Its Preliminary Molecular Mechanisms
99.
Predictive Value Of HER2 Low Expression On The Outcome And Recurrence Of Metastasis In Triple Negative Early/locally Advanced Breast Cancer Patients
100.
Clinicopathological Characteristics Of HER2 Low Expression Breast Cancer And Factors Influencing Its Efficacy With Neoadjuvant Chemotherapy
<<First
<Prev
Next>
Last>>
Jump to